Didactics Archive
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the methodology used to conduct metabolic balance studies in the EASE 5 trial of Glepaglutide.
This supplementary video complements the June 3, 2025 didacic presentation, "Metabolic Balance Studies in Intestinal Failure"
Session Date
Speaker
At the end of this activity, participants will be able to
- Review current indications for pediatric intestinal transplantation.
- Discuss advancements in surgical techniques and immunosuppression.
- Examine outcomes and emerging trends in pediatric intestinal transplantation.
Session Date
Speaker
At the end of this activity, participants will be able to
- Review the French National experience with GLP-2 in intestinal failure management.
- Analyze the outcomes and insights gained from GLP-2 use in French cohort studies.
- Discuss the implications of the French experience for future GLP-2 treatment strategies.
Session Date
Speaker
At the end of this activity, participants will be able to
- Discuss the observed recent increase in numbers of patients with concomitant IF/SGS and Chronic intestinal inflammation
- Discuss findings in endoscopies and intestinal histology that can be seen in these cases .
- Discuss proposed management strategies.
Session Date
Speaker
At the end of this activity, participants will be able to
- Recognize the impact of anatomy on intestinal failure management.
- Explore tailored medical therapies based on anatomical variations.
- Optimize outcomes through anatomy-specific management strategies.
Session Date
Speaker
At the end of this activity, participants will be able to
- Define enteral autonomy and its significance in pediatric intestinal failure.
- Identify factors influencing enteral autonomy and long-term survival in pediatric patients.
- Explore strategies to promote enteral autonomy and improve outcomes in pediatric intestinal failure.
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify criteria for diagnosing intestinal failure.
- Explore strategies to minimize unnecessary PN use.
- Promote multidisciplinary care to optimize nutrition.
Session Date
Speaker
At the end of this activity, participants will be able to
Hear from Dr. Sanjeev Arora, Founder and Executive Director of Project ECHO, as he sits down with the Health Technology Podcast to discuss the vision behind his transformative movement.
From the UCSF Rosenman Institute website:
Dr. Sanjeev Arora’s quiet determination and profound sense of purpose shine through in everything he does. A renowned liver disease specialist and visionary social entrepreneur, Dr. Arora has spent over 30 years creating innovative solutions to address some of the most critical gaps in healthcare.
As the Founder and Executive Director of Project ECHO, he has transformed healthcare equity with a revolutionary vision: democratizing specialized medical knowledge so no one, regardless of their location, is left behind. What began in 2003 as a small effort to address hepatitis C in underserved areas has grown into a global movement spanning 194 countries, empowering health workers and logging over 4 million attendances.
Dr. Arora’s passion for equity goes beyond treating diseases. His mission empowers communities to tackle systemic challenges like education and climate change while building resilient networks of knowledge that span the globe.
In this episode, Dr. Arora discusses the powerful story behind Project ECHO, the challenges of scaling such an ambitious model, and the transformative impact it has had on millions of lives. He also shares his bold vision of reaching 6 billion people and how shared expertise can strengthen entire communities.
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the current state of Intestinal Rehabilitation in 2025 including outcomes and complications
- Review the use of fiber/blenderized formula in SBS/IF
- Discuss newer therapeutic agents to enhance adaptation
Session Date
Speaker
At the end of this activity, participants will be able to
Managing the high output stoma
Session Date
Speaker
At the end of this activity, participants will be able to
Session Date
Speaker
At the end of this activity, participants will be able to
Session Date
Speaker
At the end of this activity, participants will be able to
Catheter-related Infections in Intestinal Failure: Epidemiology, Prevention and Management
Session Date
Speaker
At the end of this activity, participants will be able to
Management of Central Venous Occlusions and Stenoses
Session Date
Speaker
At the end of this activity, participants will be able to
Session Date
Speaker
At the end of this activity, participants will be able to
Using Teduglutide in Practice and Setting Individualized Goals
Session Date
Speaker
At the end of this activity, participants will be able to
- Review challenges and lessons learnt from the management of MVID patients
- Understand the value of the multidisciplinary team approach
- Discuss emerging research update in MVID
Session Date
Speaker
At the end of this activity, participants will be able to
- Review CVC role/type in intestinal failure
- Review CVC complications with focus on catheter breaks
- Discuss management options & outcomes
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the risk factor paradigm for feeding difficulties in pediatric IF
- Interpret the available literature on the prevalence of feeding difficulties in IF
- Discuss the limitations of applying current feeding disorder definitions to pediatric IF
- Propose a definition for pediatric intestinal failure-associated feeding disorder (PIFAFD)
Session Date
Speaker
At the end of this activity, participants will be able to
TBD
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize factors to consider in determining immunosuppression for intestinal transplant
- Discuss updates and new insights in immunosuppressive strategies in intestinal transplant
- Identify future directions of research to provide targeted strategies of immunosuppression
Session Date
Speaker
At the end of this activity, participants will be able to
N/A
Session Date
Speaker
At the end of this activity, participants will be able to
- Review the available options for lock therapy for central venous catheters
- Review the available data and experience with sodium bicarbonate locks for central venous catheters
- Discuss a potential multicenter trial to assess the safety and efficacy of sodium bicarbonate locks for central venous catheters in pediatric intestinal failure patients
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the impact of the microbiome in the outcomes of children with intestinal failure.
- Discuss current practices in the use of antibiotics in short bowel syndrome
- Summarize the role of antibiotics in the management of intestinal failure
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the role of minerals in growth and development of children
- Discuss the factors contributing to nutrient deficiencies in children with intestinal failure.
- Summarize monitoring and treatment recommendations for managing trace elements in pediatric intestinal failure.
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify factors leading to iron deficiency in children with intestinal failure.
- Describe caregiver perspectives regarding anemia treatment in pediatric IF.
- Discuss strategies to treat iron deficiency
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the common pitfalls in managing CIF
- Describe the principles in managing CIF
- Summarize outcomes for CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify factors to consider in formula choice for children with intestinal failure.
- Review nutritional qualities of currently available formulas.
- Summarize strategies to optimize enteral nutrition.
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand importance of anatomy in managing short bowel syndrome
- Summarize principles of medical and surgical management
- Describe advanced therapies including teduglutide and transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize principles of intestinal transplantation
- Identify different types and techniques of intestinal transplantation
- Describe surveillance in intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe surgical lengthening approaches
- Understand tissue response to applied force
- Consider intestinal growth in distraction enterogenesis
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the physiology of GLP-2 in SBS-IF
- Describe results of the STEPS Trial for teduglutide use
- Discuss differential responses to GLP2 based on intestinal anatomy
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the obstacles faced by families managing children with medical devices that assist with feeding and elimination.
- Identify the key points in management of medical devices and emergency procedures that should be communicated to community care providers.
- Apply resources to assist parents and community care providers in the safe transition to the school setting.
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe principles of dietary management in IF
- Summarize the relationship of intestinal anatomy to choice of diet
- Monitor diet progress and adaptation
Session Date
Speaker
At the end of this activity, participants will be able to
- List the indications for parenteral nutrition (PN)
- Describe the fundamentals of initiating PN
- Summarize the principles of transitioning PN to the home
Session Date
Speaker
At the end of this activity, participants will be able to
- Define chronic intestinal failure (CIF)
- Describe approaches to classify IF (acute, subacute, chronic) and short bowel syndrome (Group 1, Group 2, Group 3)
- Relate classification to prognosis of IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe host microbiota interactions in SBS
- Summarize the microbiota in SBS
- Identify current areas of research
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe anastomotic ulcerations for children with SBS
- Summarize anastomotic ulcerations treatment options
- Summarize factors that contribute to anastomotic ulcerations
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize factors that promote intestinal adaptation
- Appraise the value of a systematic approach to feeding
- Recognize strategies to optimize enteral feeding tolerance
Session Date
Speaker
At the end of this activity, participants will be able to
- Define intestinal failure and sicuss the goals of intestinal rehabilitation
- Decribe the nutritional outcomes of children undergoing intestinal rehabilitation in our program
- Discuss data on the patients who achieve enteral autonomy
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand surgical approach to children with chronic intestinal failure (CIF)
- Understand indications for STEP Enteroplasty
- Understand outcomes for STEP Enteroplasty
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe how our laboratory developed a unique model of short bowel syndrome with intestinal failure
- Consider the role of pre-clinical models
- Consider how our patient problems should inform such translational research
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the challenges of managing CIF in emerging geographies
- Challenge conventional paradigms in CIF care
- Describe outcomes for CIF care in the Iranian context
Session Date
Speaker
At the end of this activity, participants will be able to
- Discuss causes of thrombosis and thrombocytopenia
- Discuss pathophysiology and management of VITTs
- Summarize VITTs in patients with Short Bowel Syndrome
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the history of intestinal transplantation
- Describe different types of intestinal transplantation and techniques used
- Describe the current status of intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the prevalence of feeding disorders in children with short bowel syndrome (SBS)
- Understand the approach to preventing feeding disorders in pediatric SBS
- Report the best outcomes for feeding disorder prevention in pediatric SBS
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the occurrence of osteopenia/osteoporosis in CIF pre and post-intestinal transplant
- Describe evaluation of bone health in CIF
- Determine best approaches to managing bone health in CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize best practices in managing SBS
- Describe approaches to understanding prognosis and goals of care in SBS
- Discuss approaches to monitoring and preventing complications in SBS
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the principles of medical management of CIF
- Discuss the common complications in CIF
- Describe the common pitfalls in managing CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe neurodevelopment outcomes in children with intestinal failure
- Describe neurodevelopmental outcomes post-intestinal transplant in children
- Describe neurodevelopmental interventions that may improve outcomes in children with intestinal failure
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the anatomic classification for short bowel syndrome
- Describe phenotypic characteristics of the different anatomic subgroups
- Identify different approaches to management based on GI anatomy
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the process for managing central venous access (CVA) in children with IF
- Describe the need for monitoring CVA in children with IF
- Discuss the specific monitoring required to prevent infections at the access site
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the incidence of COVID-19 infection in pediatric IF and transplant patients
- Understand treatment strategies for COVID-19 in pediatric IF and transplant patients
- Report outcomes of COVID-19 in pediatric IF and intestinal transplant patients
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the current indications for intestinal transplantation
- Describe current outcomes of intestinal transplantation
- Describe potential evolving indications in intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the prevalence of SIBO in pediatric IF
- Understand the diagnosis of SIBO in pediatric IF
- Understand strategies to manage SIBO in pediatric IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the outcomes for GLP-2 in SBS-IF
- Relate outcomes for GLP-2 in SBS-IF to anatomic phenotypes of SBS
- Suggest differential algorithms for PN weaning in SBS-IF with GLP-2
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe principles of intestinal transplantation
- Describe different types and techniques of intestinal transplantation
- Describe surveillance in intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the prevalence of CLABSI in pediatric IF patients
- Describe the approach to preventing CLABSI in preventing CLABSI in pediatric IF
- Report the best outcomes for CLABSI prevention in pediatric IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the common pitfalls in managing CIF
- Describe the principles in managing CIF
- Summarize outcomes for CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the prevalence of micronutrient deficiencies in pediatric chronic IF (CIF)
- Describe approaches to correcting micronutrient deficiencies in CIF
- Discuss transitions to enteral feeding in CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the historical evolution of lipid emulsions in PN
- Discuss the currently available lipid emulsions
- Outline choice of lipid emulsions in different clinical scenarios
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand indications for starting home parenteral nutrition (HPN) in IF
- Understand principles of PN formulation
- Understand process of transition to home PN
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the occurrence of osteopenia/osteoporosis in pediatric IF
- Describe evaluation of bone health in pediatric IF
- Determine best approaches to managing bone health in chronic IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Provide the accepted definition for chronic IF
- Describe approach to classification of IF
- Relate classification to prognosis of IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the evolution of intestinal rehabilitation
- Describe current outcomes for intestinal failure
- Describe anticipated developments in pediatric intestinal failure
Session Date
Speaker
At the end of this activity, participants will be able to
- Analyze the trend of increasing hospitalizations in patients with short bowel syndrome (SBS) in the United States over a decade
- Identify the leading causes for hospital admissions in SBS patients
- Summarize the financial burden of hospitalizations in SBS patients
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the prevalence of central venous cather-related infections (CRBSI) in chronic intestinal failure CIF
- Describe approaches to reducing incidence of CRBSI in CIF
- Discuss management of CRBSI in CIF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the current role for intestinal transplantation in children
- Describe types of intestinal transplant procedures in children
- Discuss the outcomes of pediatric intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe HPN decision making in the palliative patient cohort in the UK
- Explain the practice of remote discharge examples in the UK
- Summarize palliative HPN management throughout the COVID pandemic
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the medical management of intestinal failure
- Discuss the position of growth factor use in SBS-IF
- Outline outcomes of intestinal failure
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize overall outcomes in children with GLP-2
- Outline the approach to use of GLp-2 analogs in children with SBS-IF
- Discuss real-world experience with GLP-2 use in pediatric patients with SBS-IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the management of SBS care in Europe
- Describe differences in SBS care in different geographies
- Understand approaches to developing IF expertise across Europe
Session Date
Speaker
At the end of this activity, participants will be able to
- Clinical and anatomic impact of inoperable desmoid tumors at the root of the mesentery
- Surgical approach to inoperable desmoid tumors
- Role of intestinal transplantation for desmoid tumors
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand current indications for pediatric intestinal transplantation
- Understand current outcomes for different types of intestinal transplan
- Determine limitations of current intestinal transplant indications.
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify and validate the measurement of small bowel caliber in short bowel syndrome (SBS)
- Compare and contrast the relationship between bowel dilatation and parenteral nutrition complications
- Summarize the relationship between bowel dilatation and enteral autonomy.
Session Date
Speaker
At the end of this activity, participants will be able to
- Define the spectrum of functional disorders leading to intestinal failure (IF)
- Explain the diagnosis of pseudo-obstruction
- Develop a plan to manage management of functional IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Evaluate the spectrum of functional disorders leading to IF in children
- Define the diagnosis of pseudo-obstruction in children
- Develop a plan to manage functional IF in children
Session Date
Speaker
At the end of this activity, participants will be able to
- Relate type of intestinal failure to prognosis
- Understand central-venous catheter related infection
- Understand IFALD
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize the evolution of a new national intestinal failure service
- Describe the steps in establishing a national intestinal failure service
- Summarize early outcomes for a new national intestinal failure service
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the current survival rate in pediatric IF
- Predict the likelihood of enteral autonomy in pediatric IF
- Discuss the impact of enteral autonomy in pediatric IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the radiological evaluation of loss of venous access
- Describe percutaneous techniques to regain central venous access
- Discuss role of percutaneous intervention in avoiding multivisceral transplant for complicated porto-mesenteric venous thrombosis
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the evolution of acute mesenteric ischemia
- Plan the appropriate multi-disciplinary management of acute mesenteric ischemia
- Outline outcomes of multi-disciplinary management of acute mesenteric ischemia
Session Date
Speaker
At the end of this activity, participants will be able to
- Summarize overall outcomes in children with intestinal failure
- Outline the likelihood of enteral autonomy in children with IF
- Predict the potential for enteral autonomy in pediatric patients with IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the development of intestinal transplants in Argentina
- Describe outcomes of ITX in under-resourced geographies
- Understand approaches to developing IF expertise in emerging geographies
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the pathogenesis of Type 2 IF
- Select management priorities for Type 2 IF, using the SNAP approach
- Summarize the outcomes for type 2 IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Explain the evolution of pediatric intestinal rehabilitation
- Identify current treatments for pediatric intestinal failure (IF)
- Discuss current outcomes for pediatric IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Understand the prevelance of SBS/IF treatments in South America
- Describe outcomes of IF in under-resourced geographies
- Understand approaches to developing IF expertise in emerging geographies
Session Date
Speaker
At the end of this activity, participants will be able to
- Evaluate quality of life (QoL) in intestinal failure and HPN patients
- Use qualitative approaches to study QoL of intestinal failure patients
- Summarize outcomes for current QoL studies in IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the clinical features of patients with SBS-IF and jejunostomies
- Discuss the steps in medical treatment of the high output stoma patient
- Summarize current outcomes in this group of patients
Session Date
Speaker
At the end of this activity, participants will be able to
- List the clinician's role in preparing a patient for PN weaning.
- Identify the clues that may suggest it is time for a weaning trial.
- Discuss the nutrition and hydration weaning options available to clinician and patient.
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the principles of preparing to discharge patients on PN
- Implement best practices for teaching patients/ care-providers how to manage HPN
- Describe best practices for prevention of common PN complications
Session Date
Speaker
At the end of this activity, participants will be able to
- Articulate the steps in preparing a patient for home parenteral nutrition (HPN)
- Describe the steps for safe discharge on HPN
- Develop a plan for laboratory monitoring of patients on HPN
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify indications for commencing parenteral nutrition (PN)
- Identify contraindications to commencing PN
- Analyze clinical, financial and social constraints to commencing PN
Session Date
Speaker
At the end of this activity, participants will be able to
- Determine the current and expanding indications for intestinal transplantation for SBS/IF
- Describe the choice of allograft organs in intestinal transplant
- Summarize outcomes for intestinal transplantation in the modern era
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the principles of growth factor therapy in intestinal adaptation using teduglutide as the prototype growth factor
- Summarize results of recent Phase 2 trials with long-acting growth factors in intestinal failure
- Explain the future landscape for growth factor therapy in intestinal failure
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the use of growth factors in SBS/IF
- Identify contraindications to use of growth factors in SBS/IF
- Analyze current real-world experience with use of growth factor therapy in SBS/IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the interplay of probiotics and intestinal adaptation
- Summarize the role of short chain fatty acids and diet in intestinal adaptation
- Identify current areas of research in intestinal adaptation
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify the psycho-social determinants of outcome in patients with intestinal failure
- Describe the support mechanisms required for patients with IF
- Summarize the need for psycho-social support in overall care of patients with short bowel syndrome and/or IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the principles of managing central venous access in patients on long term PN
- Evaluate catheter-related complications in patients receiving long term PN
- Manage catheter-related, PN complications
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the syndrome of liver dysfunction in patients with intestinal failure on PN
- List steps utilized in the diagnosis of IFALD
- Summarize the principles of managing IFALD and recent developments
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify community resources available for patient support and education for patients with intestinal failure
- Enumerate the benefits to patients of association with a patient support group
- Identify opportunities for peer-to - peer support for patients in the community
Session Date
Speaker
At the end of this activity, participants will be able to
- Determine the current and expanding indications for intestinal transplantation for short bowel syndrome/intestinal failure (SBS/IF)
- Describe the choice of allograft organs in intestinal transplant
- Summarize outcomes for intestinal transplantation
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe conventional surgical principles in preventing/managing short bowel syndrome/intestinal failure (SBS/IF)
- Summarize specialized surgical procedures in SBS/IF
- Evaluate outcomes for intestinal lengthening procedures
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the use of growth factors in SBS/IF
- Identify contraindications to use of growth factors in SBS/IF
- Summarize the results of growth factor therapy in SBS/IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the role of medical management of short bowel syndrome/intestinal failure (SBS/IF)
- Identify when to use anti-diarrheals in SBS/IF
- Determine the appropriateness of using growth factor therapy in overall medical management of SBS/IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Describe the diet principles that have been successful in the management of short bowel syndrome/intestinal failure (SBS/IF)
- Determine when to utilize oral rehydration solutions in SBS/IF
- Evaluate the outcomes of dietary management in overall care of SBS/IF
Session Date
Speaker
At the end of this activity, participants will be able to
- Monitor patients on long-term parenteral nutrition (PN)
- Evaluate laboratory data of patients receiving long-term PN
- Recognize and manage PN complications
Session Date
Speaker
At the end of this activity, participants will be able to
- Identify the indications for commencing parenteral nutrition (PN)
- Describe the principles of prescribing and monitoring PN
- Analyze the appropriate time and principles for transitioning a patient on PN to the home setting
Session Date
Speaker
At the end of this activity, participants will be able to
- Define and differentiate between intestinal failure (IF) and short bowel syndrome (SBS)
- Identify the types of IF based on pathophysiology
- Summarize outcomes for IF